GO:0005353 fructose transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005353 describes the molecular function that enables fructose to cross a biological membrane, a process essential for sugar uptake in intestine, kidney, liver, adipose and brain.
• The best-characterized fructose transporter is GLUT5 (SLC2A5), a facilitative diffusion carrier that moves fructose down its concentration gradient without ATP.
• GLUT8 (SLC2A8) is an intracellular hexose transporter that also accepts fructose and is linked to hepatic lipid metabolism and steatosis.
• GLUT2 (SLC2A2) can transport fructose when expressed on the cell surface, and its activity can be distinguished from GLUT5 using fructose isomer discrimination assays.
• TM4SF5 regulates hepatocyte transporters, including GLUT8, and connects fructose transport to metabolic liver disease.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools to dissect the causal roles of fructose transporters in physiology and disease.
Description
Fructose transmembrane transporter activity (GO:0005353) is a molecular function that enables the transfer of fructose from one side of a membrane to the other. Fructose exists in open-chain and ring forms, and D-fructose is the sweetest of the sugars, found free in many fruits and honey. This activity is fundamental for dietary fructose absorption, cellular energy supply, and metabolic signaling in tissues such as intestine, kidney, liver, adipose and brain. Researchers study this term to understand how sugar uptake is controlled and how its dysregulation contributes to metabolic diseases including hepatic steatosis and insulin resistance. The function is mediated by facilitative glucose transporter (GLUT) family proteins, most notably GLUT5 (SLC2A5), GLUT8 (SLC2A8) and GLUT2 (SLC2A2). GLUT5 is the archetypal fructose transporter, and its structure and transport mechanism have been resolved at high resolution. GLUT8 is an intracellular transporter that also accepts fructose and has been implicated in liver lipid metabolism. TM4SF5, a tetraspanin-like protein, regulates hepatocyte transporters including GLUT8, linking fructose transport to metabolic liver disease. Understanding GO:0005353 therefore requires integrating structural biology, cellular transport assays, and genetic models.
fructose transmembrane transporter activity At A Glance
| GO ID | GO:0005353 |
|---|---|
| GO term | fructose transmembrane transporter activity |
| Ontology | molecular_function |
| Synonym | fructose permease activity; fructose porter activity |
| Major function | Enables the transfer of fructose from one side of a membrane to the other. |
| Major proteins | GLUT5 (SLC2A5), GLUT8 (SLC2A8), GLUT2 (SLC2A2). |
| Substrate | D-fructose, which exists in open-chain and ring forms. |
| Transport type | Facilitative diffusion, driven by concentration gradient. |
| Related disease | Hepatic steatosis, metabolic liver disease, insulin resistance. |
What Is GO:0005353?
In simple terms, GO:0005353 is the activity that allows fructose to pass through a cell membrane. According to the QuickGO definition, it enables the transfer of fructose from one side of a membrane to the other, where fructose can exist in an open-chain or ring form, and D-fructose is the sweetest sugar found free in many fruits and honey. This activity is a molecular function, meaning it describes what a protein does at the molecular level rather than a whole pathway or cellular location. It is often associated with facilitative diffusion, in which a carrier protein binds fructose and undergoes conformational changes to release it on the other side of the membrane without direct ATP hydrolysis. The activity can be measured in live cells using fructose isomers and fluorescent or radioactive tracers.
Why Is fructose transmembrane transporter activity Important in Cell Biology?
Fructose transmembrane transporter activity is important because it controls the entry of a highly lipogenic sugar into cells, influencing energy storage, lipid synthesis and metabolic signaling. In the intestine, GLUT5-mediated fructose uptake is the first step in dietary fructose absorption, and in the liver, fructose transport contributes to steatosis and insulin resistance. Because fructose is metabolized differently from glucose, its transport activity is a key node linking diet to metabolic disease. Understanding this activity also informs drug development and nutritional strategies for conditions such as non-alcoholic fatty liver disease and type 2 diabetes.
• Dietary fructose absorption in the small intestine depends on GLUT5-mediated transport.
• Hepatic fructose uptake contributes to de novo lipogenesis and steatosis.
• GLUT8 is an intracellular fructose transporter linked to lipid droplet metabolism.
• TM4SF5 regulates hepatocyte transporters and is implicated in metabolic liver disease.
• Fructose transport activity can be assayed in live cells using fructose isomers.
• Essential amino acids for GLUT5-mediated fructose transport have been identified.
• Altered fructose transport is associated with insulin resistance and obesity.
• GLUT2 can also transport fructose and is important for bidirectional sugar flux.
• Fructose transporter activity is a potential target for metabolic disease therapeutics.
• CRISPR models enable causal testing of fructose transporter genes in disease.
What Happens During fructose transmembrane transporter activity?
Substrate recognition and binding
In simple terms: The transporter first grabs fructose from one side of the membrane.
Fructose transmembrane transporter activity begins with substrate recognition, where the transporter binds D-fructose in either its open-chain or ring form. GLUT5 exhibits stereospecific recognition of fructose, and specific amino acid residues are essential for this binding and subsequent transport. Structural studies of GLUT5 have revealed the architecture of the substrate-binding site and the residues that coordinate fructose.
Conformational change and translocation
In simple terms: The transporter changes shape to carry fructose across the membrane.
After binding, the transporter undergoes conformational changes that move fructose from one side of the membrane to the other. This process is consistent with an alternating-access mechanism, in which the substrate-binding site is exposed alternately to the extracellular and intracellular sides. GLUT8 similarly functions as an intracellular hexose transporter that can translocate fructose across membranes.
Release and reset
In simple terms: Fructose is released inside the cell, and the transporter resets for another round.
Following translocation, fructose is released on the opposite side of the membrane, and the transporter returns to its initial conformation to allow another transport cycle. This cycle does not require direct ATP hydrolysis and is driven by the fructose concentration gradient. GLUT2 can also mediate fructose transport when present at the cell surface, and its activity can be distinguished from GLUT5 using fructose isomer discrimination assays.
Regulation by interacting proteins
In simple terms: Other proteins can switch fructose transport on or off.
Fructose transport activity is regulated by interacting proteins such as TM4SF5, which modulates hepatocyte transporters including GLUT8 during metabolic liver diseases. This regulation links fructose transport to cellular metabolic state and disease progression. The interplay between TM4SF5 and GLUT8 influences fructose metabolism in hepatic steatosis.
Key Genes Involved in GO:0005353 fructose transmembrane transporter activity
The following genes and proteins are directly implicated in fructose transmembrane transporter activity or its regulation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC2A5 (GLUT5) | Primary fructose transporter; facilitative diffusion of fructose. | Structural and functional studies of fructose transport; intestinal fructose absorption. |
| SLC2A8 (GLUT8) | Intracellular hexose transporter that accepts fructose. | Hepatic steatosis, lipid droplet metabolism, insulin-responsive tissues. |
| SLC2A2 (GLUT2) | Bidirectional sugar transporter that can transport fructose. | Live-cell assays distinguishing GLUT5 and GLUT2 activity. |
| TM4SF5 | Regulates hepatocyte transporters including GLUT8. | Metabolic liver disease, fructose metabolism in steatosis. |
| SLC2A1 (GLUT1) | Glucose transporter with low fructose affinity; context-dependent. | Comparative studies of hexose transporter specificity. |
| SLC2A3 (GLUT3) | Neuronal glucose transporter; fructose transport less characterized. | Neuronal sugar transport research. |
| SLC2A4 (GLUT4) | Insulin-responsive glucose transporter; fructose transport minor. | Insulin signaling and metabolic disease models. |
| SLC2A6 (GLUT6) | Intracellular hexose transporter; fructose transport not well defined. | Comparative transporter biology. |
| SLC2A7 (GLUT7) | Intestinal hexose transporter; fructose transport reported. | Intestinal sugar absorption studies. |
| SLC2A9 (GLUT9) | Urate and hexose transporter; fructose transport context-dependent. | Urate metabolism and fructose interplay. |
| SLC2A10 (GLUT10) | Hexose transporter; fructose transport not well characterized. | Comparative studies. |
| SLC2A11 (GLUT11) | Hexose transporter; fructose transport reported. | Muscle and adipose sugar transport. |
| SLC2A12 (GLUT12) | Insulin-responsive hexose transporter; fructose transport unclear. | Metabolic disease research. |
| SLC2A13 (GLUT13) | Myo-inositol transporter; fructose transport not established. | Comparative transporter studies. |
| SLC2A14 (GLUT14) | Hexose transporter; fructose transport not well defined. | Testis and metabolic research. |
| HK1 (Hexokinase 1) | Phosphorylates fructose to trap it intracellularly. | Fructose metabolism downstream of transport. |
| ALDOB (Aldolase B) | Metabolizes fructose-1-phosphate in liver. | Hereditary fructose intolerance models. |
| KHK (Ketohexokinase) | Phosphorylates fructose in liver; links transport to lipogenesis. | Hepatic steatosis and fructose metabolism. |
How Is fructose transmembrane transporter activity Regulated?
Fructose transmembrane transporter activity is regulated at multiple levels. TM4SF5 modulates hepatocyte transporters, including GLUT8, during metabolic liver diseases, thereby influencing fructose metabolism in hepatic steatosis. GLUT8 is an intracellular transporter whose trafficking and activity are linked to insulin-responsive tissues and lipid droplet metabolism. GLUT5 activity depends on specific amino acid residues that are essential for fructose transport, and mutations in these residues can alter transport capacity. Additionally, GLUT2 can contribute to fructose transport when present at the cell surface, and its activity can be distinguished from GLUT5 using fructose isomer discrimination assays.
fructose transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC2A8 (GLUT8) | Hepatic steatosis, lipid droplet metabolism | Knockout and overexpression in hepatocyte cell lines |
| TM4SF5 | Metabolic liver disease, fructose metabolism | Knockout and knock-in in hepatic cells |
| SLC2A5 (GLUT5) | Intestinal fructose malabsorption | Point mutations in transport residues |
| SLC2A2 (GLUT2) | Bidirectional sugar transport, diabetes | Live-cell transport assays with fructose isomers |
| KHK | Hereditary fructose intolerance, lipogenesis | Knockout in liver cell models |
Hepatic steatosis and metabolic liver disease
Fructose transmembrane transporter activity is directly linked to hepatic steatosis through GLUT8 and TM4SF5. TM4SF5 regulates hepatocyte transporters including GLUT8, and this crosstalk influences fructose metabolism in hepatic steatosis. Dysregulated fructose transport can promote lipid accumulation and metabolic liver disease progression.
Insulin resistance and type 2 diabetes
Altered fructose transport contributes to insulin resistance and type 2 diabetes by increasing hepatic fructose uptake and lipogenesis. GLUT8 is an insulin-responsive intracellular transporter, and its regulation is relevant to metabolic disease. Understanding fructose transporter activity may inform therapeutic strategies for diabetes and related disorders.
Intestinal fructose malabsorption
GLUT5-mediated fructose transport is essential for intestinal fructose absorption, and impaired activity can lead to fructose malabsorption. Essential amino acids for GLUT5-mediated fructose transport have been identified, providing insight into how mutations might affect absorption. Live-cell assays using fructose isomers can help characterize transport defects.
From fructose transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GLUT8 loss alter fructose transport and lipid accumulation? | SLC2A8 knockout hepatocyte cell line |
| Which residues are essential for GLUT5-mediated fructose transport? | Point mutations in SLC2A5 |
| Can GLUT2 and GLUT5 be distinguished in live cells? | Knock-in of tagged transporters and fructose isomer assays |
| Does TM4SF5 regulate hepatocyte fructose transporters? | TM4SF5 knockout and overexpression in liver cells |
| How does fructose transport affect insulin signaling? | Overexpression of GLUT8 in insulin-responsive cells |
| Can fructose transport be redirected to glucose? | Knock-in of GLUT5 variants with altered specificity |
How to Study the fructose transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Live-cell fructose uptake assay | Fructose transport activity | Screening GLUT5 and GLUT2 activity |
| Site-directed mutagenesis | Essential residues for transport | Mapping GLUT5 transport mechanism |
| Cryo-EM / X-ray crystallography | Transporter structure | Understanding conformational changes |
| CRISPR knockout | Loss-of-function effects | Testing causal roles in steatosis |
| CRISPR knock-in | Tagged or mutant transporters | Live-cell imaging of transport |
| RNA-seq | Transcriptional changes | Pathway analysis in metabolic disease |
| Proteomics | Protein interactions | Identifying TM4SF5-GLUT8 crosstalk |
| Lipid droplet imaging | Lipid accumulation | Hepatic steatosis models |
Live-cell fructose transport assays
Fructose transport activity can be measured in live cells using fructose isomers that discriminate between GLUT5 and GLUT2 activity. These assays allow real-time monitoring of fructose uptake and can be adapted to high-throughput screening.
Structural biology and mutagenesis
Structural studies of GLUT5 have revealed the substrate-binding site and transport mechanism, and mutagenesis of essential amino acids can confirm their role in fructose transport. These approaches provide mechanistic insight into GO:0005353.
CRISPR-based genetic screens
CRISPR knockout and knock-in screens can identify genes that regulate fructose transport activity and its downstream metabolic effects. Such screens are useful for discovering novel regulators of fructose metabolism.
Metabolic and lipid profiling
Fructose transport activity can be linked to lipid droplet formation and steatosis using metabolic profiling and imaging. These methods help connect transporter function to disease phenotypes.
How CRISPR Can Be Used to Study GO:0005353 fructose transmembrane transporter activity
Knockout
CRISPR knockout of SLC2A8 or TM4SF5 can test whether these genes are required for fructose transport and lipid accumulation in hepatocytes. Knockout models help establish causality between transporter activity and metabolic phenotypes.
Point Mutation
Point mutations in SLC2A5 can be introduced to identify amino acids essential for fructose transport, as demonstrated by mutagenesis studies. Such models allow precise structure-function analysis of GO:0005353.
Knock-in
Knock-in of tagged or fluorescently labeled transporters enables live-cell imaging and discrimination of GLUT5 and GLUT2 activity using fructose isomers. This approach is valuable for studying transporter trafficking and localization.
Overexpression
Overexpression of GLUT8 or GLUT5 in cell lines can enhance fructose transport and reveal downstream metabolic effects such as lipid droplet formation. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports fructose transmembrane transporter activity Research
Researchers studying fructose transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in fructose transport, metabolic regulation, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional validation of genes linked to GO:0005353.
Contact EDITGENE today to design your custom CRISPR model for fructose transmembrane transporter activity research.
Frequently Asked Questions About fructose transmembrane transporter activity
What is fructose transmembrane transporter activity?
It is a molecular function (GO:0005353) that enables the transfer of fructose from one side of a membrane to the other, as defined by QuickGO and supported by studies on GLUT5 and GLUT8.
What genes are involved in fructose transmembrane transporter activity?
Key genes include SLC2A5 (GLUT5), SLC2A8 (GLUT8), SLC2A2 (GLUT2), and regulatory proteins such as TM4SF5.
Which protein is the primary fructose transporter?
GLUT5 (SLC2A5) is the best-characterized facilitative fructose transporter, and its structure and mechanism have been resolved.
How is fructose transport measured in the lab?
Live-cell assays using fructose isomers can simultaneously measure GLUT5 and GLUT2 activity.
What diseases are linked to fructose transport?
Hepatic steatosis, metabolic liver disease, insulin resistance, and intestinal fructose malabsorption are linked to altered fructose transport.
Does GLUT8 transport fructose?
Yes, GLUT8 is an intracellular hexose transporter that accepts fructose and is implicated in hepatic steatosis.
What is the role of TM4SF5 in fructose metabolism?
TM4SF5 regulates hepatocyte transporters including GLUT8 and influences fructose metabolism in metabolic liver disease.
Can CRISPR be used to study fructose transporters?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are used to dissect fructose transporter function.
What are the synonyms for GO:0005353?
The synonyms are fructose permease activity and fructose porter activity, as listed in QuickGO.
Why is fructose transport important for liver disease?
Fructose uptake in the liver contributes to de novo lipogenesis and steatosis, and its regulation by TM4SF5 and GLUT8 is linked to metabolic liver disease.
Conclusion
Fructose transmembrane transporter activity (GO:0005353) is a central molecular function that controls fructose entry into cells and influences metabolic health. The best-characterized transporters, GLUT5 and GLUT8, along with regulatory proteins such as TM4SF5, provide a framework for understanding how fructose transport contributes to hepatic steatosis, insulin resistance, and intestinal absorption. CRISPR-based models are powerful tools for causally testing these genes and for developing new therapeutic strategies targeting fructose transport.
References
- 2. Selinger M et al.. 2022. Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors.. Comput Struct Biotechnol J 20:2759-2777 PMID: 35685361
- 3. Lee H et al.. 2022. Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis.. Mol Metab 58:101451 PMID: 35123128
- 4. Schmidt S et al.. 2009. GLUT8, the enigmatic intracellular hexose transporter.. Am J Physiol Endocrinol Metab 296(4):E614-8 PMID: 19176349
- 5. Nomura N et al.. 2015. Structure and mechanism of the mammalian fructose transporter GLUT5.. Nature 526(7573):397-401 PMID: 26416735
- 6. Kim JE et al.. 2022. TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases.. Int J Mol Sci 23(15) PMID: 35955521
- 7. Gora N et al.. 2023. Discrimination of GLUTs by Fructose Isomers Enables Simultaneous Screening of GLUT5 and GLUT2 Activity in Live Cells.. ACS Chem Biol 18(5):1089-1100 PMID: 37116192
- 8. Ebert K et al.. 2018. Identification of essential amino acids for glucose transporter 5 (GLUT5)-mediated fructose transport.. J Biol Chem 293(6):2115-2124 PMID: 29259131
